|Updated: 5/08/2012 2:29 pm
||Published: 5/08/2012 12:21 pm
LITTLE ROCK, Ark. (AP) - Arkansas Attorney General Dustin McDaniel has announced the settlement of two cases involving the pharmaceutical company Abbott Laboratories.
McDaniel said Tuesday that Abbott will pay Arkansas a total of $3.03 million as part of a $1.6 billion multi-state settlement.
One case involves Abbott's "off-label" marketing of the drug Depakote. McDaniel says the Federal Drug Administration has approved the drug for use in treating seizure disorders, mania associated with bipolar disorder and migraines. He said Abbott also marketed the drug for unapproved uses - including schizophrenia, agitated dementia and autism.
The second settlement involves allegations of Medicaid fraud against Abbott.
(Copyright 2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)